Vivani, Novo Nordisk Sign Agreement To Evaluate Weight Management Implant

KUALA LUMPUR, July 8 (Bernama) -- Vivani Medical Inc (Vivani), a biopharmaceutical company developing ultra long-acting drug implants, has signed an agreement with Novo Nordisk to evaluate its semaglutide drug implant, NPM-139, for chronic weight management.

AGC Biologics, Pyramid Pharma Services To Provide Integrated Manufacturing Solution

KUALA LUMPUR, July 1 (Bernama) -- AGC Biologics, a global biopharmaceutical contract development and manufacturing organisation (CDMO), has partnered with Pyramid Pharma Services to provide an integrated United States (US)-based manufacturing solution for drug developers.

Countries Seeking To Develop AI Capabilities Need To Navigate Trusted Partner Networks, Says Expert

By Siti Radziah Hamzah

TASHKENT, June 18 (Bernama) -- Countries seeking to develop artificial intelligence (AI) capabilities will need to navigate new alliances, controls and trusted partner networks as the technology increasingly becomes a geopolitical issue, said an expert today.